2013 & 2014 | 2015 & 2016 | 2017 & 2018 | 2019 & 2020 | 2021 & 2022 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
N | 236 | 291 | 349 | 363 | 335 | |||||
Age | 64 | 58–71 | 66 | 56–73 | 68 | 59–77 | 71 | 60–78 | 71 | 61–78 |
Female | 24.58% | 19.52 − 30.45% | 21.65% | 17.30 − 26.74% | 26.65% | 22.28 − 31.52% | 34.71% | 30.00 − 39.74% | 26.27% | 21.85 − 31.23% |
BMI | 28 | 25–33 | 28 | 25–32 | 28 | 25–32 | 28 | 25–33 | 29 | 26–33 |
Smoking History | 56.78% | 50.40 − 62.94% | 64.95% | 59.31 − 70.20% | 56.73% | 51.49 − 61.83% | 53.44% | 48.30 − 58.51% | 63.28% | 57.99 − 68.26% |
Diabetes | 27.54% | 22.23 − 33.56% | 29.55% | 24.60 − 35.03% | 28.65% | 24.16 − 33.61% | 35.81% | 31.05 − 40.87% | 31.94% | 27.18 − 37.11% |
Dyslipidaemia | 57.63% | 51.25 − 63.76% | 69.07% | 63.54 − 74.10% | 68.77% | 63.73 − 73.41% | 66.67% | 61.67 − 71.32% | 70.75% | 65.67 − 75.36% |
Hypertension | 70.73% | 64.17 − 76.53% | 78.01% | 72.90 − 82.39% | 72.21% | 67.29 − 76.65% | 74.10% | 69.36 − 78.34% | 72.54% | 67.53 − 77.04% |
Cerebrovascular disease | 8.47% | 5.38 − 13.09% | 11.34% | 8.19 − 15.50% | 10.03% | 7.30 − 13.63% | 8.82% | 6.32 − 12.19% | 10.45% | 7.61 − 14.19% |
Peripheral vascular disease | 5.93% | 3.44 − 10.04% | 6.87% | 4.49 − 10.37% | 7.16% | 4.90 − 10.36% | 5.23% | 3.37 − 8.02% | 5.37% | 3.42 − 8.33% |
Previous MI | 35.17% | 28.96 − 41.92% | 43.64% | 38.06 − 49.38% | 44.99% | 39.85 − 50.24% | 29.48% | 25.02 − 34.37% | 22.99% | 18.81 − 27.79% |
History of CHF | 30.51% | 24.61 − 37.12% | 25.77% | 21.08 − 31.09% | 24.93% | 20.68 − 29.73% | 33.06% | 28.42 − 38.05% | 27.16% | 22.68 − 32.16% |
Cardiogenic shock | 1.27% | 0.40 − 3.93% | 3.44% | 1.88 − 6.21% | 1.15% | 0.45 − 2.91% | 2.75% | 1.50 − 4.99% | 2.69% | 1.42 − 5.03% |
Prior CTS intervention | 6.78% | 4.07 − 11.08% | 13.40% | 9.96 − 17.79% | 15.47% | 12.05 − 19.64% | 23.42% | 19.36 − 28.04% | 20.30% | 16.34 − 24.93% |
Category of surgery | 236 | 291 | 349 | 363 | 335 | |||||
CABG | 60.17% | 53.81 − 66.20% | 58.42% | 52.68 − 63.94% | 49.86% | 44.64 − 55.08% | 34.44% | 29.74 − 39.47% | 31.94% | 27.18 − 37.11% |
Valve | 22.03% | 17.21 − 27.74% | 25.09% | 20.46 − 30.37% | 34.96% | 30.15 − 40.10% | 55.10% | 49.96 − 60.14% | 54.93% | 49.58 − 60.17% |
CABG + Valve | 7.63% | 4.88 − 11.74% | 10.31% | 7.32 − 14.34% | 8.88% | 6.33 − 12.33% | 8.54% | 6.08 − 11.87% | 8.06% | 5.60 − 11.47% |
Other | 10.17% | 6.93 − 14.69% | 6.19% | 3.95 − 9.57% | 6.30% | 4.20 − 9.36% | 1.93% | 0.94 − 3.93% | 5.07% | 3.19 − 7.97% |
Death* | 1.89% | 0.13 − 8.62% | 2.92% | 0.61 − 9.09% | 2.84% | 0.94 − 6.93% | 1.67% | 0.30 − 5.67% | 2.06% | 0.26 − 7.82% |
Rerturn to theatre* | 4.07% | 1.05 − 10.10% | 10.82% | 3.87 − 20.49% | 8.45% | 3.37 − 16.59% | 6.31% | 2.69 − 12.24% | 9.29% | 5.49 − 15.79% |
CPB time (min) | 86.50 | 73–125 | 91.50 | 74–132 | 83.50 | 63–129 | 90.50 | 70–133 | 92.00 | 69–134 |
LOS > 14 (days) | 5.50 | 4–10 | 5.00 | 4–9 | 5.00 | 4–8 | 5.50 | 4–8 | 6.00 | 2–9 |